Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1609286 | 0.83 | CNR2 (0.59) | CNR2CNR1 | |
| SCHEMBL1608362 | 0.81 | CNR2 (0.55) | CNR2CNR1 | |
| SCHEMBL1610036 | 0.78 | CNR2 (0.70) | CNR2CNR1 | |
| SCHEMBL3997990 | 0.77 | CNR2 (0.67) | CNR2CNR1 | |
| SCHEMBL1608343 | 0.77 | CNR2 (0.57) | CNR2CNR1 | |
| SCHEMBL1609904 | 0.76 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL4002183 | 0.75 | CNR2 (0.66) | CNR2CNR1 | |
| SCHEMBL4469036 | 0.75 | KMT2A (0.51) | CNR2 | |
| SCHEMBL5181993 | 0.74 | CNR2 (0.62) | CNR2CNR1 | |
| SCHEMBL1609416 | 0.74 | CNR2 (0.58) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2010526-A1 | BENZIMIDAZOLE 5-SULFONAMIDE DERIVATIVES AS CANNABINOID 1 (CB1) RECEPTOR LIGANDS | AstraZeneca AB (SE) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007120101-A1 | BENZIMIDAZOLE 5-SULFONAMIDE DERIVATIVES AS CANNABINOID 1 (CB1) RECEPTOR LIGANDS | ASTRAZENECA AB (SE) | 2007-10-25 | — | — | WO | disclosed |